SCHEMBL19677013

SCHEMBL19677013

O=C1CCC(NCc2ccc(O)c(CN3CCNCC3)c2)(c2ccccc2F)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 1/20 0.66
▸ NR1D2 Q14995 1/20 0.66
▸ HDAC1 Q13547 1/20 0.36
▸ CHRM3 P20309 8/20 0.34
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ OPRL1 P41146 1/20 0.33
▸ CRBN Q96SW2 1/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ SOS1 Q07889 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16636418 0.91 NR1D1 (0.79) NR1D1NR1D2HDAC1CHRM3CHRM2
SCHEMBL16636363 0.89 NR1D1 (0.83) NR1D1NR1D2HDAC1BACE1CA1
Hydrochloric Acid SCHEMBL17982778 0.88 NR1D1 (0.81) NR1D1NR1D2HDAC1BACE1CA1
SCHEMBL18021946 0.82 NR1D1 (0.83) NR1D1NR1D2BACE1
Hydrochloric Acid SCHEMBL16636450 0.81 NR1D1 (0.82) NR1D1NR1D2BACE1
SCHEMBL16636237 0.80 NR1D1 (0.84) NR1D1NR1D2BACE1SIGMAR1
SCHEMBL16636446 0.79 NR1D2 (1.00) NR1D1NR1D2HDAC1BACE1
SCHEMBL16636464 0.79 NR1D2 (0.85) NR1D1NR1D2BACE1
SCHEMBL29378837 0.79 NR1D2 (1.00) NR1D1NR1D2HDAC1BACE1
Hydrochloric Acid SCHEMBL16636462 0.79 NR1D1 (0.82) NR1D1NR1D2BACE1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055293-B1 DIARYLALKYLAMINE REV-ERB ANTAGONISTS AND THEIR USE AS MEDICAMENTS FOND ST ITALIANO TECNOLOGIA (IT) 2017-12-06 — — EP disclosed
Send feedback